Alzheimer's disease: L-carnitine has shown improvements or slower declines in the mental ability of people with Alzheimer's disease
However, people with MS who also have obesity or type 2 diabetes may be candidates for GLP-1 therapy, says Alan David Kaye, MD, PhD, a professor and the vice chair of research in the anesthesiology department at LSU Health in Shreveport, Louisiana
October 10, 2025: Ozempic Vision Loss MDL Hearing Scheduled for December A hearing has been scheduled for December that could help decide whether GLP-1 vision loss lawsuits will be grouped together in federal court
How glutathione functions in the body Your cells use glutathione in two states: reduced (GSH) and oxidized (GSSG)
Can adding magnesium or other minerals reduce the acidity or improve the flavor of coffee
Reach your assigned physician anytime through our patient portal, 24/7